Survival Markedly Improved in Diffuse Large B-Cell Lymphoma with Everolimus, R-CHOP Combo Therapy
News
Combining everolimus, an inhibitor of the PI3K-mTOR pathway, with the standard R-CHOP therapy may greatly increase the cure rate of diffuse large B-cell lymphoma (DLBCL) patients who have not been previously ... Read more